Table 1.
Mass effects of the tumor |
Headache |
Visual field defects |
Hyperprolactinemia |
Pituitary stalk section |
Hypopituitarism |
Hypothyroidism, hypogonadism, hypocortisolism |
Systemic effects of GH/IGF-I excess |
Visceromegaly |
Soft tissue and skin changes |
Thickening of acral parts |
Increased skin thickness and soft tissue hypertrophy |
Hyperhidrosis/Oily texture |
Skin tags and acanthosis nigricans |
Cardiovascular features |
Hypertrophy (biventricular or asymmetric septal) |
Congestive Heart Failure (systolic and/or diastolic) |
Coronary disease |
Arrhythmias |
Hipertensión |
Cardiomyopathy |
Metabolic features |
Impaired glucose tolerance |
Diabetes mellitus |
Insulin resistance |
Respiratory manifestations |
Macroglossia |
Jaw malocclusion |
Upper airway obstruction |
Sleep disturbances |
Sleep apnea (central and obstructive) |
Ventilatory dysfunction |
Bone and joint manifestations |
Increased articular cartilage thickness |
Arthralgias and arthritis |
Carpal tunnel síndrome |
Osteopenia |
Other endocrine consequences |
Goiter |
Hypercalciuria |
Galactorrhea |
Decrease libido, impotents |
Menstrual abnormalities |
Modified from Cordero and Barkan [61].